Literature DB >> 19777993

Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research.

Philippe Guillaume1, Danijel Dojcinovic, Immanuel F Luescher.   

Abstract

Soluble MHC-peptide complexes, commonly known as tetramers, allow the detection and isolation of antigen-specific T cells. Although other types of soluble MHC-peptide complexes have been introduced, the most commonly used MHC class I staining reagents are those originally described by Altman and Davis. As these reagents have become an essential tool for T cell analysis, it is important to have a large repertoire of such reagents to cover a broad range of applications in cancer research and clinical trials. Our tetramer collection currently comprises 228 human and 60 mouse tetramers and new reagents are continuously being added. For the MHC II tetramers, the list currently contains 21 human (HLA-DR, DQ and DP) and 5 mouse (I-A(b)) tetramers. Quantitative enumeration of antigen-specific T cells by tetramer staining, especially at low frequencies, critically depends on the quality of the tetramers and on the staining procedures. For conclusive longitudinal monitoring, standardized reagents and analysis protocols need to be used. This is especially true for the monitoring of antigen-specific CD4+ T cells, as there are large variations in the quality of MHC II tetramers and staining conditions. This commentary provides an overview of our tetramer collection and indications on how tetramers should be used to obtain optimal results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19777993      PMCID: PMC2935769     

Source DB:  PubMed          Journal:  Cancer Immun        ISSN: 1424-9634


  55 in total

1.  Cutting edge: detection of antigen-specific CD4+ T cells by HLA-DR1 oligomers is dependent on the T cell activation state.

Authors:  T O Cameron; J R Cochran; B Yassine-Diab; R P Sékaly; L J Stern
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 2.  The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining.

Authors:  Victor Appay; Sarah L Rowland-Jones
Journal:  J Immunol Methods       Date:  2002-10-01       Impact factor: 2.303

Review 3.  Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors.

Authors:  Gerd Müller; Uta E Höpken; Harald Stein; Martin Lipp
Journal:  J Leukoc Biol       Date:  2002-07       Impact factor: 4.962

4.  Soluble major histocompatibility complex-peptide octamers with impaired CD8 binding selectively induce Fas-dependent apoptosis.

Authors:  Philippe Guillaume; Daniel F Legler; Nicole Boucheron; Marie-Agnès Doucey; Jean-Charles Cerottini; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

5.  Developmentally regulated glycosylation of the CD8alphabeta coreceptor stalk modulates ligand binding.

Authors:  A M Moody; D Chui; P A Reche; J J Priatel; J D Marth; E L Reinherz
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

6.  The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire.

Authors:  J Hernández; P P Lee; M M Davis; L A Sherman
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 7.  Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

Authors:  Ulrich Keilholz; Jeffrey Weber; James H Finke; Dmitry I Gabrilovich; W Martin Kast; Mary L Disis; John M Kirkwood; Carmen Scheibenbogen; Jeff Schlom; Vernon C Maino; H Kim Lyerly; Peter P Lee; Walter Storkus; Franceso Marincola; Alexandra Worobec; Michael B Atkins
Journal:  J Immunother       Date:  2002 Mar-Apr       Impact factor: 4.456

Review 8.  The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma.

Authors:  Andrea Anichini; Claudia Vegetti; Roberta Mortarini
Journal:  Cancer Immunol Immunother       Date:  2004-06-03       Impact factor: 6.968

9.  Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

Authors:  Daniel E Speiser; Mikaël J Pittet; Philippe Guillaume; Norbert Lubenow; Eric Hoffman; Jean-Charles Cerottini; Pedro Romero
Journal:  J Immunother       Date:  2004 Jul-Aug       Impact factor: 4.456

10.  Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function.

Authors:  Hiroko Tomiyama; Hiroshi Takata; Tomoko Matsuda; Masafumi Takiguchi
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

View more
  8 in total

1.  MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer.

Authors:  Caroline Poli; Caroline Raffin; Danijel Dojcinovic; Immanuel Luescher; Maha Ayyoub; Danila Valmori
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

2.  Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers.

Authors:  Maha Ayyoub; Danijel Dojcinovic; Pascale Pignon; Isabelle Raimbaud; Julien Schmidt; Immanuel Luescher; Danila Valmori
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 3.  Missing: a diagnostic technique to enumerate antigen-specific T cells.

Authors:  Melinda Shelley Suchard
Journal:  Crit Rev Oncol Hematol       Date:  2011-12-03       Impact factor: 6.312

4.  Reversible major histocompatibility complex I-peptide multimers containing Ni(2+)-nitrilotriacetic acid peptides and histidine tags improve analysis and sorting of CD8(+) T cells.

Authors:  Julien Schmidt; Philippe Guillaume; Melita Irving; Petra Baumgaertner; Daniel Speiser; Immanuel F Luescher
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

Review 5.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

6.  Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.

Authors:  Julien Schmidt; Danijel Dojcinovic; Philippe Guillaume; Immanuel Luescher
Journal:  Front Immunol       Date:  2013-07-30       Impact factor: 7.561

7.  Detection of Foreign Antigen-specific CD4(+)Foxp3(+) Regulatory T Cells by MHC Class II Tetramer and Intracellular CD154 Staining.

Authors:  Jin Young Choi; Seong Kug Eo
Journal:  Immune Netw       Date:  2013-12-20       Impact factor: 6.303

Review 8.  Immune monitoring in cancer vaccine clinical trials: critical issues of functional flow cytometry-based assays.

Authors:  Iole Macchia; Francesca Urbani; Enrico Proietti
Journal:  Biomed Res Int       Date:  2013-09-30       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.